Literature DB >> 15627022

Palliative care in patients with primary brain tumors.

Sophie Taillibert1, Florence Laigle-Donadey, Marc Sanson.   

Abstract

PURPOSE OF REVIEW: Because patients with primary brain tumors often present severe functional impairment as well as behavioral/cognitive dysfunction, they suffer from greater dependency and hopelessness than other cancer patients. Optimal management should not only focus on symptom relief through medication and physiotherapy, but should also take into account the psychosocial burden of the disease on the patients and their caregivers. This review updates available data on supportive care in patients with brain tumor. RECENT
FINDINGS: Recent improvements have been made in the management of several complications of brain tumor: pain, epilepsy, and side effects of antiepileptic drugs; disability and related thromboembolic complications; cognitive disorders of mixed (tumoral and/or iatrogenic) origin; side effects of steroids; fatigue; and psychological consequences of the disease.
SUMMARY: Avoiding useless "overtreatment" is the governing idea. A very thorough evaluation of the benefit/risk ratios is needed each time a new treatment is being considered. Brain tumor patients are particularly prone to develop severe side effects, increased fatigue, and cognitive deterioration following apparently minor changes in symptomatic treatments. Care is also needed to avoid useless prolongation of a burdensome situation. Another issue is that patients and their caregivers should benefit from the support of a multidisciplinary team to maintain realistic hopes and to anticipate critical decisions. Finally, guidelines from the literature are proposed to improve physicians' communication skills when treating these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15627022     DOI: 10.1097/01.cco.0000142075.75591.02

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  21 in total

1.  The relationship between function, quality of life and coping in patients with low-grade gliomas.

Authors:  Margareta Gustafsson; Tanja Edvardsson; Gerd Ahlström
Journal:  Support Care Cancer       Date:  2006-05-19       Impact factor: 3.603

2.  End of life issues in brain tumor patients.

Authors:  Andrea Pace; Cherubino Di Lorenzo; Cherubino Di Lorenzo; Lara Guariglia; Bruno Jandolo; Carmine M Carapella; Alfredo Pompili
Journal:  J Neurooncol       Date:  2008-08-14       Impact factor: 4.130

3.  Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.

Authors:  Marta Maschio; L Dinapoli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

4.  Taking care of patients with brain tumor-related epilepsy: results from an Italian survey.

Authors:  Marta Maschio; Francesco Paladin
Journal:  Neurol Sci       Date:  2014-07-26       Impact factor: 3.307

5.  Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.

Authors:  Rifaquat Rahman; Paul J Catalano; David A Reardon; Andrew D Norden; Patrick Y Wen; Eudocia Q Lee; Lakshmi Nayak; Rameen Beroukhim; Ian F Dunn; Alexandra J Golby; Mark D Johnson; E Antonio Chiocca; Elizabeth B Claus; Brian M Alexander; Nils D Arvold
Journal:  J Neurooncol       Date:  2015-06-02       Impact factor: 4.130

6.  Stress and intervention preferences of patients with brain tumors.

Authors:  Stephen T Keir; Ann Bebe Guill; Karen E Carter; Henry S Friedman
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

7.  Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.

Authors:  M Maschio; L Dinapoli; M Mingoia; F Sperati; A Pace; A Pompili; C M Carapella; A Vidiri; P Muti
Journal:  J Neurol       Date:  2011-06-16       Impact factor: 4.849

Review 8.  The end-of-life phase of high-grade glioma patients: a systematic review.

Authors:  Eefje M Sizoo; H Roeline W Pasman; Linda Dirven; Christine Marosi; Wolfgang Grisold; Günther Stockhammer; Jonas Egeter; Robin Grant; Susan Chang; Jan J Heimans; Luc Deliens; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  Support Care Cancer       Date:  2013-12-14       Impact factor: 3.603

9.  Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.

Authors:  Florien W Boele; Wopke Hoeben; Karen Hilverda; Jeroen Lenting; Anne-Lucia Calis; Eefje M Sizoo; Emma H Collette; Jan J Heimans; Martin J B Taphoorn; Jaap C Reijneveld; Martin Klein
Journal:  J Neurooncol       Date:  2012-12-02       Impact factor: 4.130

10.  The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.

Authors:  Marta Maschio; Loredana Dinapoli; Antonello Vidiri; Andrea Pace; Alessandra Fabi; Alfredo Pompili; Maria Carmine Carapella; Bruno Jandolo
Journal:  J Exp Clin Cancer Res       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.